Polomar Health Services, Inc. (PMHS) stock
PMHSOTCPharmaceutical PreparationsFiscal year ends December 31
$0.12−0.01 (-4.00%)
Close on Oct 19, 2026Market cap $3.37MP/E –Yield –
Polomar Health Services gross margin
Gross margin is gross profit as a percentage of revenue.
Polomar Health Services's gross margin for the twelve months ending Jun 30, 2026 was 61.1%. For fiscal 2025 it was 71.0%, against 52.5% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 71.0% | +18.4 |
| FY2024 | Dec 31, 2024 | 52.5% | −37.2 |
| FY2023 | Dec 31, 2023 | 89.7% | −10.3 |
| FY2022 | Dec 31, 2022 | 100.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 61.2% | −8.8 |
| Q1 FY2026 | Mar 31, 2026 | 54.7% | −15.3 |
| Q4 FY2025 | Dec 31, 2025 | 71.0% | +27.5 |
| Q3 FY2025 | Sep 30, 2025 | 70.1% | −19.9 |
| Q2 FY2025 | Jun 30, 2025 | 70.1% | −0.7 |
| Q1 FY2025 | Mar 31, 2025 | 70.1% | +50.1 |
| Q4 FY2024 | Dec 31, 2024 | 43.5% | −43.7 |
| Q3 FY2024 | Sep 30, 2024 | 90.0% | −2.9 |
| Q2 FY2024 | Jun 30, 2024 | 70.8% | −29.2 |
| Q1 FY2024 | Mar 31, 2024 | 19.9% | −80.1 |
| Q4 FY2023 | Dec 31, 2023 | 87.1% | – |
| Q3 FY2023 | Sep 30, 2023 | 92.9% | – |
| Q4 FY2022 | Dec 31, 2022 | 100.0% | – |
| Q3 FY2022 | Sep 30, 2022 | 100.0% | – |
See a number that looks wrong?